看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | No | No |
| Is net profit margin increasing? | No | No |
| Is asset turnover increasing? | Yes | No |
| Is equity multiplier increasing? | Yes | Yes |
| Competitors Used |
|---|
| Curis, Inc. |
| Neurogene Inc. |
| I-Mab |
| XOMA Royalty Corporation |
| Karyopharm Therapeutics Inc. |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| CRIS | NGNE | IMAB | XOMA | KPTI | INMB | |||
| Return On Equity | ||||||||
| Latest Twelve Months | -436% | -30% | -37% | -23% | 47% | -121% | ||
| Fiscal Year - 1 | -83% | NA | -64% | -44% | 187% | -62% | ||
| Fiscal Year - 2 | -41% | NA | -46% | -17% | 343% | -39% | ||
| Fiscal Year - 3 | -62% | NA | 25% | 7% | 852% | -51% | ||
| Fiscal Year - 4 | 167% | NA | 99% | 13% | -391% | -39% | ||
| Fiscal Year - 5 | -334% | NA | 63% | -6% | -171% | NA | ||
| Average | -131% | -30% | 7% | -12% | 145% | -62% | ||
| Median | -72% | -30% | -6% | -12% | 117% | -51% | ||
| Benchmarks | Ticker | |||||||
| Curis, Inc. | NasdaqCM:CRIS | |||||||
| Neurogene Inc. | NasdaqGM:NGNE | |||||||
| I-Mab | NasdaqGM:IMAB | |||||||
| XOMA Royalty Corporation | NasdaqGM:XOMA | |||||||
| Karyopharm Therapeutics Inc. | NasdaqGS:KPTI | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | CRIS | NGNE | IMAB | XOMA | KPTI | INMB | ||
| Latest Fiscal Year | Dec-23 | Dec-24 | Dec-23 | Dec-24 | Dec-24 | Dec-24 | ||
| LTM Period | Sep-24 | Dec-24 | Sep-24 | Dec-24 | Dec-24 | Dec-24 | ||
| Revenues | ||||||||
| Latest Twelve Months | 10 | 1 | 1 | 28 | 145 | 0 | ||
| Fiscal Year | 10 | 1 | 4 | 28 | 145 | 0 | ||
| Fiscal Year - 1 | 10 | NA | (32) | 5 | 146 | 0 | ||
| Fiscal Year - 2 | 11 | NA | 14 | 6 | 157 | 0 | ||
| Fiscal Year - 3 | 11 | NA | 236 | 38 | 210 | 0 | ||
| Fiscal Year - 4 | 10 | NA | 4 | 29 | 108 | 0 | ||
| Fiscal Year - 5 | 10 | NA | 8 | 18 | 41 | NA | ||
| Net Income | ||||||||
| Latest Twelve Months | (45) | (75) | (88) | (19) | (76) | (42) | ||
| Fiscal Year | (47) | (75) | (206) | (19) | (76) | (42) | ||
| Fiscal Year - 1 | (57) | 14 | (364) | (46) | (143) | (30) | ||
| Fiscal Year - 2 | (45) | (55) | (367) | (23) | (165) | (27) | ||
| Fiscal Year - 3 | (30) | (51) | 72 | 8 | (124) | (30) | ||
| Fiscal Year - 4 | (32) | NA | (213) | 9 | (196) | (12) | ||
| Fiscal Year - 5 | (33) | NA | (59) | (2) | (200) | (8) | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | 90 | 223 | 358 | 234 | 240 | 57 | ||
| Latest Fiscal Quarter | 42 | 336 | NA | 221 | 164 | 40 | ||
| Fiscal Year | 77 | 336 | 368 | 221 | 164 | 40 | ||
| Fiscal Year - 1 | 109 | 223 | 591 | 234 | 240 | 57 | ||
| Fiscal Year - 2 | 162 | 109 | 881 | 140 | 358 | 82 | ||
| Fiscal Year - 3 | 204 | 101 | 970 | 167 | 305 | 100 | ||
| Fiscal Year - 4 | 35 | NA | 250 | 125 | 313 | 41 | ||
| Fiscal Year - 5 | 37 | NA | 345 | 96 | 295 | 24 | ||
| Fiscal Year - 6 | 74 | NA | 158 | 64 | 341 | 17 | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | 30 | 186 | 235 | 89 | (136) | 37 | ||
| Latest Fiscal Quarter | (9) | 310 | 237 | 82 | (186) | 32 | ||
| Fiscal Year | 20 | 310 | 242 | 82 | (186) | 32 | ||
| Fiscal Year - 1 | 47 | 186 | 422 | 89 | (136) | 37 | ||
| Fiscal Year - 2 | 91 | (146) | 717 | 124 | (17) | 60 | ||
| Fiscal Year - 3 | 131 | (92) | 862 | 142 | (80) | 80 | ||
| Fiscal Year - 4 | (34) | NA | (292) | 86 | 51 | 39 | ||
| Fiscal Year - 5 | (4) | NA | (139) | 44 | 50 | 24 | ||
| Fiscal Year - 6 | 24 | NA | (46) | 19 | 183 | 17 | ||